What is the recommended stepwise management for osteoarthritis?

Stepwise Management of Osteoarthritis

All patients with symptomatic osteoarthritis should receive three core treatments immediately and simultaneously: patient education, structured exercise (both strengthening and aerobic), and weight loss interventions if BMI ≥25 kg/m² 1, 2, 3.

Step 1: Core Treatments (Universal - Start Here)

These are non-negotiable foundational interventions that every patient must receive:

• Patient education: Address the misconception that OA is inevitably progressive and untreatable. Provide written and oral information 1.
• Structured exercise program: Include local muscle strengthening AND general aerobic fitness training. For knee OA specifically, add neuromuscular education and self-management programs 2, 3.
• Weight loss: Mandatory for patients with BMI ≥25 kg/m² who have knee or hip OA 1, 2, 3.

Critical point: These core treatments must continue throughout all subsequent steps—they are not replaced by pharmacological interventions 1.

Step 2: Adjunct Non-Pharmacological Treatments

Add these based on specific joint involvement and functional limitations:

• For knee OA: Tai chi (strong recommendation), balance exercises, yoga, kinesiotaping 3
• For hand OA (first CMC joint): Hand orthoses 3
• For tibiofemoral knee OA: Tibiofemoral bracing 3
• Assistive devices: Walking sticks for those with gait instability, tap turners and other aids for activities of daily living 1
• Additional modalities: Local heat/cold applications, TENS, manipulation and stretching (particularly for hip OA) 1

Avoid: Do NOT use electroacupuncture. Evidence for acupuncture is insufficient despite trials 1. Do NOT recommend glucosamine or chondroitin—these are explicitly not recommended 1, 2.

Step 3: First-Line Pharmacological Treatment

For Knee and Hand OA:

Start with paracetamol (acetaminophen) at regular dosing AND/OR topical NSAIDs 1, 3. Topical NSAIDs receive a strong recommendation specifically for knee OA 3.

For Knee OA Specifically:

Consider topical capsaicin as an alternative first-line option 1, 3.

Important safety consideration: The 2019 ACR guideline notes that acetaminophen receives only a conditional recommendation, reflecting evolving evidence about its limited efficacy 3. However, given its superior safety profile compared to oral NSAIDs, it remains appropriate as initial therapy.

Step 4: Second-Line Pharmacological Treatment

If paracetamol and/or topical NSAIDs provide insufficient relief:

Option A: Add or substitute oral NSAIDs or COX-2 inhibitors

• Use the lowest effective dose for the shortest duration 1
• Always co-prescribe a proton pump inhibitor (choose the lowest acquisition cost) 1
• First choice should be either a COX-2 inhibitor (excluding etoricoxib 60 mg) OR a standard NSAID 1
• Critical safety assessment: Before prescribing, evaluate gastrointestinal, cardiovascular, liver, and renal risk factors. Age is a major consideration 1
• For patients on low-dose aspirin: Exhaust other analgesic options before adding NSAIDs/COX-2 inhibitors 1

Option B: Add opioid analgesics

• Tramadol receives conditional recommendation 3
• However, oral and transdermal opioids are strongly NOT recommended by the 2019 OARSI guidelines due to safety concerns 4
• Consider duloxetine as an alternative for pain management 3

Divergence in evidence: The 2008 NICE guidelines 1 suggest opioids as an option, while more recent 2019 guidelines 4 strongly recommend against them. Given the priority on morbidity and mortality, avoid routine opioid use except in highly selected cases where benefits clearly outweigh risks.

Step 5: Intra-articular Injections

For Knee OA:

• Intra-articular corticosteroid injections: Strong recommendation for moderate to severe pain 1, 3. Evidence supports their use 3.
• Hyaluronic acid injections: The evidence is contradictory. AAOS 2014 guidelines strongly recommend AGAINST hyaluronic acid 2, while OARSI 2019 conditionally recommends it 4. Given this conflict and prioritizing safety/cost-effectiveness, do not routinely use hyaluronic acid injections 2.

For Hand OA:

• Intra-articular corticosteroid injections and chondroitin sulfate receive conditional recommendations 3

For Hip OA:

• Evidence for intra-articular corticosteroid injections is inconclusive 2
• Hyaluronic acid is consistently NOT recommended 5

Step 6: Surgical Referral

Refer for joint replacement surgery when:

• Joint symptoms (pain, stiffness, reduced function) substantially affect quality of life
• Symptoms are refractory to non-surgical treatment
• Refer BEFORE prolonged functional limitation and severe pain become established 1

Do NOT refer for:

• Arthroscopic lavage and debridement (not recommended routinely) 1
• Exception: Knee OA with clear mechanical locking—not for "giving way," gelling, or radiographic loose bodies 1

Patient-specific factors (age, sex, smoking, obesity, comorbidities) should NOT be barriers to surgical referral 1.

Common Pitfalls to Avoid

1. Skipping core treatments: Pharmacological interventions are adjuncts, not replacements, for exercise, education, and weight management 1.

2. Prescribing glucosamine/chondroitin: Multiple high-quality guidelines explicitly recommend against these 1, 2.

3. Using hyaluronic acid for knee OA: Despite some conditional recommendations, the strongest evidence (AAOS) recommends against it 2.

4. Delaying surgical referral: Refer before severe, established disability develops 1.

5. Prescribing NSAIDs without gastroprotection: Always co-prescribe a PPI 1.

6. Ignoring cardiovascular risk: In patients with cardiovascular comorbidities or frailty, oral NSAIDs are not recommended 4.

Assessment Throughout

At each visit, assess the effect of OA on function, quality of life, occupation, mood, relationships, and leisure activities 1. Provide periodic review tailored to individual needs and formulate management plans in partnership with the patient 1.